Veru to report fiscal 2022 fourth quarter and full year financial results on december 5, 2022

Miami, nov. 28, 2022 (globe newswire) -- veru inc. (nasdaq: veru), a biopharmaceutical company focused on developing novel medicines for covid-19 and other viral ards-related diseases and for oncology, today announced it will host a conference call and audio webcast on monday, december 5, 2022, at 8:00 a.m. et to discuss its fiscal 2022 fourth quarter and full year ended september 30, 2022 financial results and provide a business update.
VERU Ratings Summary
VERU Quant Ranking